Literature DB >> 25872870

Casein kinase 2 (CK2) phosphorylates the deubiquitylase OTUB1 at Ser16 to trigger its nuclear localization.

Lina Herhaus1, Ana B Perez-Oliva1, Giorgio Cozza2, Robert Gourlay1, Simone Weidlich1, David G Campbell1, Lorenzo A Pinna2, Gopal P Sapkota3.   

Abstract

The deubiquitylating enzyme OTUB1 is present in all tissues and targets many substrates, in both the cytosol and nucleus. We found that casein kinase 2 (CK2) phosphorylated OTUB1 at Ser(16) to promote its nuclear accumulation in cells. Pharmacological inhibition or genetic ablation of CK2 blocked the phosphorylation of OTUB1 at Ser(16), causing its nuclear exclusion in various cell types. Whereas we detected unphosphorylated OTUB1 mainly in the cytosol, we detected Ser(16)-phosphorylated OTUB1 only in the nucleus. In vitro, Ser(16)-phosphorylated OTUB1 and nonphosphorylated OTUB1 exhibited similar catalytic activity, bound K63-linked ubiquitin chains, and interacted with the E2 enzyme UBE2N. CK2-mediated phosphorylation and subsequent nuclear localization of OTUB1 promoted the formation of 53BP1 (p53-binding protein 1) DNA repair foci in the nucleus of osteosarcoma cells exposed to ionizing radiation. Our findings indicate that the activity of CK2 is necessary for the nuclear translocation and subsequent function of OTUB1 in DNA damage repair.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25872870      PMCID: PMC4421874          DOI: 10.1126/scisignal.aaa0441

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  52 in total

1.  The raison d'être of constitutively active protein kinases: the lesson of CK2.

Authors:  Lorenzo A Pinna
Journal:  Acc Chem Res       Date:  2003-06       Impact factor: 22.384

Review 2.  Protein kinase CK2: a challenge to canons.

Authors:  Lorenzo A Pinna
Journal:  J Cell Sci       Date:  2002-10-15       Impact factor: 5.285

Review 3.  How druggable is protein kinase CK2?

Authors:  Giorgio Cozza; Andrea Bortolato; Stefano Moro
Journal:  Med Res Rev       Date:  2010-05       Impact factor: 12.944

4.  The selectivity of inhibitors of protein kinase CK2: an update.

Authors:  Mario A Pagano; Jenny Bain; Zygmunt Kazimierczuk; Stefania Sarno; Maria Ruzzene; Giovanni Di Maira; Matthew Elliott; Andrzej Orzeszko; Giorgio Cozza; Flavio Meggio; Lorenzo A Pinna
Journal:  Biochem J       Date:  2008-11-01       Impact factor: 3.857

Review 5.  Protein kinase CK2 in health and disease: Structural bases of protein kinase CK2 inhibition.

Authors:  R Battistutta
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

6.  14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking.

Authors:  Mercedes Pozuelo Rubio; Kathryn M Geraghty; Barry H C Wong; Nicola T Wood; David G Campbell; Nick Morrice; Carol Mackintosh
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

7.  CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3.

Authors:  Thorsten Mueller; Peter Breuer; Ina Schmitt; Jochen Walter; Bernd O Evert; Ullrich Wüllner
Journal:  Hum Mol Genet       Date:  2009-06-19       Impact factor: 6.150

8.  OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis.

Authors:  Tycho E T Mevissen; Manuela K Hospenthal; Paul P Geurink; Paul R Elliott; Masato Akutsu; Nadia Arnaudo; Reggy Ekkebus; Yogesh Kulathu; Tobias Wauer; Farid El Oualid; Stefan M V Freund; Huib Ovaa; David Komander
Journal:  Cell       Date:  2013-07-03       Impact factor: 41.582

9.  The mechanism of OTUB1-mediated inhibition of ubiquitination.

Authors:  Reuven Wiener; Xiangbin Zhang; Tao Wang; Cynthia Wolberger
Journal:  Nature       Date:  2012-02-22       Impact factor: 49.962

10.  Protein associated with SMAD1 (PAWS1/FAM83G) is a substrate for type I bone morphogenetic protein receptors and modulates bone morphogenetic protein signalling.

Authors:  Janis Vogt; Kevin S Dingwell; Lina Herhaus; Robert Gourlay; Thomas Macartney; David Campbell; James C Smith; Gopal P Sapkota
Journal:  Open Biol       Date:  2014-02-19       Impact factor: 6.411

View more
  24 in total

Review 1.  Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer.

Authors:  Matthew Saldana; Kacey VanderVorst; Anastasia L Berg; Hyun Lee; Kermit L Carraway
Journal:  Endocr Relat Cancer       Date:  2019-01-01       Impact factor: 5.678

2.  N6-Furfuryladenine is protective in Huntington's disease models by signaling huntingtin phosphorylation.

Authors:  Laura E Bowie; Tamara Maiuri; Melanie Alpaugh; Michelle Gabriel; Nicolas Arbez; Danny Galleguillos; Claudia L K Hung; Shreya Patel; Jianrun Xia; Nicholas T Hertz; Christopher A Ross; David W Litchfield; Simonetta Sipione; Ray Truant
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-09       Impact factor: 11.205

3.  Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy.

Authors:  Yan Zhao; Xinping Huang; Dan Zhu; Min Wei; Jiechen Luo; Shuyu Yu; Yonglu Tian; Xiaofeng Zheng
Journal:  Cell Death Differ       Date:  2022-06-29       Impact factor: 15.828

4.  Phosphorylation of OTUB1 at Tyr 26 stabilizes the mTORC1 component, Raptor.

Authors:  Seung Un Seo; Seon Min Woo; Min Wook Kim; Eun-Woo Lee; Kyoung-Jin Min; Taeg Kyu Kwon
Journal:  Cell Death Differ       Date:  2022-08-04       Impact factor: 12.067

Review 5.  CK2 and the Hallmarks of Cancer.

Authors:  May-Britt Firnau; Angela Brieger
Journal:  Biomedicines       Date:  2022-08-16

6.  OTUD4 Is a Phospho-Activated K63 Deubiquitinase that Regulates MyD88-Dependent Signaling.

Authors:  Yu Zhao; Miranda C Mudge; Jennifer M Soll; Rachel B Rodrigues; Andrea K Byrum; Elizabeth A Schwarzkopf; Tara R Bradstreet; Steven P Gygi; Brian T Edelson; Nima Mosammaparast
Journal:  Mol Cell       Date:  2018-02-01       Impact factor: 17.970

7.  A novel cell-penetrating peptide protects against neuron apoptosis after cerebral ischemia by inhibiting the nuclear translocation of annexin A1.

Authors:  Xing Li; Lu Zheng; Qian Xia; Lu Liu; Meng Mao; Huijuan Zhou; Yin Zhao; Jing Shi
Journal:  Cell Death Differ       Date:  2018-05-16       Impact factor: 15.828

8.  The DUF1669 domain of FAM83 family proteins anchor casein kinase 1 isoforms.

Authors:  Luke J Fulcher; Polyxeni Bozatzi; Theresa Tachie-Menson; Kevin Z L Wu; Timothy D Cummins; Joshua C Bufton; Daniel M Pinkas; Karen Dunbar; Sabin Shrestha; Nicola T Wood; Simone Weidlich; Thomas J Macartney; Joby Varghese; Robert Gourlay; David G Campbell; Kevin S Dingwell; James C Smith; Alex N Bullock; Gopal P Sapkota
Journal:  Sci Signal       Date:  2018-05-22       Impact factor: 8.192

9.  CX-4945 and siRNA-Mediated Knockdown of CK2 Improves Cisplatin Response in HPV(+) and HPV(-) HNSCC Cell Lines.

Authors:  Janeen H Trembley; Bin Li; Betsy T Kren; Amy A Gravely; Emiro Caicedo-Granados; Mark A Klein; Khalil Ahmed
Journal:  Biomedicines       Date:  2021-05-18

Review 10.  Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code.

Authors:  Yanfeng Wang; Feng Wang
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.